Vanguard Capital Management
FOLD

Vanguard Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,023,557
Closed -$203M – 4115
2026
Q1 		$203M Buy
+14,023,557
New +$201M 0.01% 1054

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vanguard Capital Management's FOLD Position: Q2 2026 in Review

Vanguard Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 14,023,557 shares — an estimated $203M sold.

Vanguard Capital Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $203M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Vanguard Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Capital Management sold 14,023,557 Amicus Therapeutics shares in Q2 2026, an estimated $203M.
  • Vanguard Capital Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Vanguard Capital Management's Amicus Therapeutics position peaked at $203M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.